Neuropediatrics 2014; 45(05): 328-332
DOI: 10.1055/s-0034-1378130
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Refractory Absence Epilepsy and Glut1 Deficiency Syndrome: A New Case Report and Literature Review

Francesca Ragona
1   Department of Pediatric Neuroscience, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy
,
Sara Matricardi
1   Department of Pediatric Neuroscience, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy
2   Department of Pediatrics, University of Chieti, Chieti, Italy
,
Barbara Castellotti
3   Clinical Neurophysiology and Epilepsy Center, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy
,
Mara Patrini
1   Department of Pediatric Neuroscience, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy
,
Elena Freri
1   Department of Pediatric Neuroscience, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy
,
Simona Binelli
4   Unit of Genetics of Neurodegenerative and Metabolic Diseases, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy
,
Tiziana Granata
1   Department of Pediatric Neuroscience, Foundation I.R.C.C.S. Neurological Institute C. Besta, Milan, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

27. Dezember 2013

29. März 2014

Publikationsdatum:
03. Juni 2014 (online)

Preview

Abstract

We report a 12-year-old female patient with a mild phenotype of glucose transporter type 1 deficiency syndrome (Glut1D). The clinical picture was characterized by refractory absence epilepsy, migraine, and learning disabilities. Absence seizures appeared at the age of 4 years, and electroencephalogram (EEG) showed irregular discharges of diffuse epileptic abnormalities. During the follow-up, seizures became drug resistant, cognitive evaluation revealed learning difficulties, and the patient complained migraine episodes. The evidence of seizure worsening before meals and the drug resistance suggested a Glut1D. Molecular analysis of SLC2A1 gene showed the presence of a pathogenic de novo mutation of the gene in heterozygosity (p.Ala275Thr, c.823G > A). Our case and the review of literature data on patients with Glut1D and absences provide a combination of clinical and EEG keys that should prompt the genetic analysis. The Glut1D should be suspected when absence seizures are associated with at least one among: irregular ictal EEG discharges, mild mental retardation, migraine, microcephaly, drug resistance, and worsening during fasting. An early diagnosis allows to establish one of the available ketogenic regimens which could modify the natural history of this treatable condition.